Stock Quote
Advanced Cell Technology, Inc. (ACTC.OB) (OTC BB)
$0.11
27 Nov 2009
+0.00%
$0.11
$0.11
2,851,375
$0.11
$0.10
$0.96
$0.01
-3.12
7,643,310
ACTC.OB
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Caldwell, William | Chairman of the Board, Chief Executive Officer | 350,995 |
| Lanza, Robert | Chief Scientific Officer | 493,873 |
| Shapiro, Alan | Director | -- |
Profile
Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company has acquired, developed and maintain a portfolio of patents and patent applications that form the base... Full Description
Company Address
Advanced Cell Technology, Inc.
381 Plantation Street
Worcester MA 01605
P: +1510.7484900
381 Plantation Street
Worcester MA 01605
P: +1510.7484900
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Geron Corporation | $5.33 | -0.13 |
| Genzyme Corporation | $51.07 | -0.45 |
| StemCells, Inc. | $1.07 | -0.02 |
| ACTC.OB | Industry | |
|---|---|---|
| P/E(TTM) | -- | 13.11 |
| P/S(TTM) | 52.62 | 32.32 |
| ROI(TTM) | -- | 2.21 |
| ROE(TTM) | -- | 3.47 |
No consensus estimates data available.
| Total Revenue | $0.24M |
| Net Income | $-29.44M |
| EPS | $-0.06 |
